COVID-19 in lung transplant recipients-Risk prediction and outcomes
Jan C Kamp, Jan B Hinrichs, Jan Fuge, Raphael Ewen, Jens Gottlieb, Jan C Kamp, Jan B Hinrichs, Jan Fuge, Raphael Ewen, Jens Gottlieb
Abstract
Patients after lung transplantation are at risk for life-threatening infections. Recently, several publications on COVID-19 outcomes in this patient population appeared, but knowledge on optimal treatment, mortality, outcomes, and appropriate risk predictors is limited. A retrospective analysis was performed in a German high-volume lung transplant center between 19th March 2020 and 18th May 2021. Impact of COVID-19 on physical and psychological health, clinical outcomes, and mortality were analyzed including follow-up visits up to 12 weeks after infection in survivors. Predictive parameters on survival were assessed using univariate and multivariate proportional hazards regression models. Out of 1,046 patients in follow-up, 31 acquired COVID-19 during the pandemic. 12 of 31 (39%) died and 26 (84%) were hospitalized. In survivors a significant decline in exercise capacity (p = 0.034), TLC (p = 0.02), and DLCO (p = 0.007) was observed at follow-up after 3 months. Anxiety, depression, and self-assessed quality of life remained stable. Charlson comorbidity index predicted mortality (HR 1.5, 1.1-2.2; p = 0.023). In recipients with pre-existing CLAD, mortality and clinical outcomes were inferior. However, pre-existing CLAD did not predict mortality. COVID-19 remains a life-threatening disease for lung transplant recipients, particularly in case comorbidities. Further studies on long term outcomes and impact on pre-existing CLAD are needed.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- World Health Organization. Coronavirus disease (COVID-19). Weekly epidemiological update on COVID-19–8 June 2021. [Internet]. Accessed June, 06, 2021.
- Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020. May;39(5):405–407. doi: 10.1016/j.healun.2020.03.012 Epub 2020 Mar 20.
- Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020. Aug 11;324(6):603–605. doi: 10.1001/jama.2020.12603
- Park DH, Fuge J, Meltendorf T, Kahl KG, Richter MJ, Gall H, et al.. Impact of Sars-CoV-2-Pandemic on mental disorders and quality of life in patients with pulmonary arteriaI hypertension. Front Psychiatry. 2021. Jun 24;12:668647. doi: 10.3389/fpsyt.2021.668647
- Messika J, Eloy P, Roux A, Hirschi S, Nieves A, Le Pavec J, et al.. COVID-19 in Lung Transplant Recipients. Transplantation. 2021. Jan 1;105(1):177–186. doi: 10.1097/TP.0000000000003508
- Myers CN, Scott JH, Criner GJ, Cordova FC, Mamary AJ, Marchetti N, et al.. COVID-19 in lung transplant recipients. Transpl Infect Dis. 2020. Dec;22(6):e13364. doi: 10.1111/tid.13364 Epub 2020 Jul 22.
- Saez-Giménez B, Berastegui C, Barrecheguren M, Revilla-López E, Los Arcos I, Alonso R, et al.. COVID-19 in lung transplant recipients: A multicenter study. Am J Transplant. 2021. May;21(5):1816–1824. doi: 10.1111/ajt.16364 Epub 2020 Nov 7.
- Verleden GM, Godinas L, Lorent N, Van Bleyenbergh P, Dupont L, Delcroix M, et al.. COVID-19 in lung transplant patients: A case series. Am J Transplant. 2020. Nov;20(11):3234–3238. doi: 10.1111/ajt.16212 Epub 2020 Aug 29.
- Kates OS, Haydel BM, Florman SS, Rana MM, Chaudhry ZS, Ramesh MS, et al.. COVID-19 in solid organ transplant: A multi-center cohort study. Clin Infect Dis. 2020. Aug 7:ciaa1097. doi: 10.1093/cid/ciaa1097 Epub ahead of print.
- Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, Martínez-Fernández JR, Crespo M, Gayoso J, et al.. COVID-19 in transplant recipients: The Spanish experience. Am J Transplant. 2021. May;21(5):1825–1837. doi: 10.1111/ajt.16369 Epub 2020 Nov 10.
- Aversa M, Benvenuto L, Anderson M, Shah L, Robbins H, Pereira M, et al.. COVID-19 in lung transplant recipients: A single center case series from New York City. Am J Transplant. 2020. Nov;20(11):3072–3080. doi: 10.1111/ajt.16241 Epub 2020 Sep 5.
- Hadi YB, Naqvi SF, Kupec JT, Sofka S, Sarwari A. Outcomes of Coronavirus Infectious Disease -19 (COVID-19) in Solid Organ Transplant Recipients: A Propensity Matched Analysis of a Large Research Network. Transplantation. 2021. Feb 5. doi: 10.1097/TP.0000000000003670 Epub ahead of print.
- Kayser MZ, Valtin C, Greer M, Karow B, Fuge J, Gottlieb J. Video Consultation during the Covid-19 pandemic: A single center’s experience with lung transplant recipients. Telemed J E Health. 2020. Oct 14. doi: 10.1089/tmj.2020.0170 Online ahead of print.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. doi: 10.1016/0021-9681(87)90171-8
- World Health Organization. Clinical management of COVID-19: interim guidance. May; 2020; [Internet]. Accessed June, 09, 2021.
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.. Standardisation of spirometry. Eur Respir J. 2005. Aug;26(2):319–38. doi: 10.1183/09031936.05.00034805
- Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al.. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017. Jan 3;49(1):1600016. doi: 10.1183/13993003.00016-2016 Erratum in: Eur Respir J. 2018 Nov 22;52(5).
- Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, et al.. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment—A consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant. 2019. May;38(5):493–503. doi: 10.1016/j.healun.2019.03.009
- Euro QoL Group. Euro Qol—a new facility for the measurement of health-related quality of life. Health Policy. 1990. Dec;16(3):199–208. doi: 10.1016/0168-8510(90)90421-9
- Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al.. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010. Apr;122(1–2):86–95. doi: 10.1016/j.jad.2009.06.019 Epub 2009 Jul.
- Public Health England. Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01, technical briefing 3. London, United Kingdom: Public Health England; 2020. [Internet]. Accessed June, 11, 2021.
- Simonson TS, Baker TL, Banzett RB, Bishop T, Dempsey JA, Feldman JL, et al.. Silent hypoxaemia in COVID-19 patients. J Physiol. 2021. Feb;599(4):1057–1065. doi: 10.1113/JP280769 Epub 2021 Jan 4.
- Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al.. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020. Sep;8(9):853–862. doi: 10.1016/S2213-2600(20)30316-7 Epub 2020 Jul 28.
- Permpalung N, Bazemore K, Chiang TP, Mathew J, Barker L, Nematollahi S, et al.. Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-Control Study. doi: 10.1097/TP.0000000000003839 Published online ahead of print.
- Vandervest KM, Zamora MR. Respiratory viral infections post-lung transplantation. Curr Respir Care Rep. 2012;1(3):162–167. doi: 10.1007/s13665-012-0017-x
- Miele M, Busà R, Russelli G, Sorrentino MC, Di Bella M, Timoneri F, et al.. Impaired anti-SARS-CoV-2 Humoral and Cellular Immune Response induced by Pfizer-BioNTech BNT162b2 mRNA Vaccine in Solid Organ Transplanted Patients. Am J Transplant. 2021. May 31. doi: 10.1111/ajt.16702 Epub ahead of print.
Source: PubMed